ELEX Biotech LLC

About:

Elex biotech develops drugs for the treatment of cardiovascular diseases.

Website: https://www.elexbiotech.com

Top Investors: National Institutes of Health

Description:

ELEX Biotech develops small-molecule pharmaceutical drugs for the management and cure of cardiovascular diseases such as heart failure and arrhythmias, enabling physicians to offer effective treatments for heart-related diseases. These compounds modulate the function of calcium channels that control the contraction of cardiac muscle.

Total Funding Amount:

$1.4M

Headquarters Location:

Portland, Oregon, United States

Founded Date:

2009-01-01

Founders:

Doug Kawahara, Guy Salama, Jonathan Abramson, Sandra Shotwell, Xander Wehrens

Number of Employees:

1-10

Last Funding Date:

2014-11-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai